{"filing":{"accession_number":"0001384101-26-000042","cik":"0001384101","ticker":"VCYT","company_name":"VERACYTE, INC.","form":"8-K","filing_date":"2026-07-30","report_date":"2026-07-30","primary_document":"vcyt-20260730.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1384101/000138410126000042/vcyt-20260730.htm"},"events":[{"id":22190,"run_id":20061,"accession_number":"0001384101-26-000042","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Veracyte issued a press release on July 30, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, disclosing total revenue of $150.3 million (15% YoY growth), testing revenue of $145.7 million (19% YoY growth), GAAP net income of $25.5 million, and adjusted EBITDA of $44.0 million. The filing explicitly states this is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes key financial highlights, business milestones (product launches), and updated 2026 guidance.","company_name":"VERACYTE, INC.","ticker":"VCYT","filing_date":"2026-07-30","form":"8-K","submitted_at":null,"items":[{"id":22059,"accession_number":"0001384101-26-000042","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Veracyte issued a press release on July 30, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, disclosing total revenue of $150.3 million (15% YoY growth), testing revenue of $145.7 million (19% YoY growth), GAAP net income of $25.5 million, and adjusted EBITDA of $44.0 million. The filing explicitly states this is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes key financial highlights, business milestones (product launches), and updated 2026 guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-31T00:12:03.345768+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22059,"accession_number":"0001384101-26-000042","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Veracyte issued a press release on July 30, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, disclosing total revenue of $150.3 million (15% YoY growth), testing revenue of $145.7 million (19% YoY growth), GAAP net income of $25.5 million, and adjusted EBITDA of $44.0 million. The filing explicitly states this is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The disclosure includes key financial highlights, business milestones (product launches), and updated 2026 guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-31T00:12:03.345768+00:00","company_name":"VERACYTE, INC.","ticker":"VCYT","filing_date":"2026-07-30"}]}